Announcement

The Roskamp Institute Memory Center and Clinical Trials Division is pleased to announce the addition of Ms. Yahdinah Alvarez to the clinical team.  Ms. Alvarez is an experienced clinical trial coordinator with expertise in Alzheimer’s and Parkinson’s disease studies.  If you or your loved one is suffering with Alzheimer’s disease or Parkinson’s disease, please contact […]

Continue reading


Do You Or Someone You Care For Suffer From Alzheimer’s Disease?

ALZHEIMER’S DISEASE A research study is being conducted in our area to evaluate an investigational medication for Alzheimer’s disease. Qualified participants may receive: – Study related medical care – Study medication – Compensation for time and travel Please call now for more info:    Dr. Andrew Keegan 941-256-8018 ext. 353 The Roskamp Institute Memory Clinic and […]

Continue reading


NEWS RELEASE:Investigational Immune Intervention Slows Brain Atrophy in Alzheimer’s Patients

Media Contact: Cheryl Rindfleisch, Roskamp Institute 941-256-8018 x356 crindfleisch@rfdn.org or Jeffree Itrich  858-622-5827 jitrich@ucsd.edu May 10, 2010 Investigational Immune Intervention Slows Brain Atrophy in Alzheimer’s Patients 18-Month Phase 2 Study is First to Show Combined Benefits of IGIV on Clinical Outcomes and Brain-Imaging Measures Phase 3 Study Now Enrolling Participants at the Roskamp Institute in […]

Continue reading


FREE MEMORY SCREENING-Sarasota FL

Are you or someone you know suffering from memory loss or forgetfulness? Roskamp Institute is offering FREE MEMORY SCREENING for adults age 60 or older. For an appointment call:               Roskamp Institute 941-256-8018 ext. 349 The Roskamp Institute Memory Clinic and Clinical Trials Division provide a full range of services for individuals with Alzheimer’s disease […]

Continue reading


High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer’s disease patients

Alzheimer’s disease is clinically characterized by progressive cognitive decline accompanied by the presence of amyloid plaques and neurofibrillary tangles in the brain of Alzheimer’s patients. A small protein fragment beta-amyloid (Abeta) with 42 amino acids is shown to deposit earlier in the disease process than the slightly shorter form (40 amino acid fragment).  Both species […]

Continue reading


Alzheimer’s Disease Anti-Inflammatory Prevention Trial

The Roskamp Institute Memory Center is actively following a large number of subjects who participated in the Alzheimer’s Disease Anti-Inflammatory Prevention Trial (ADAPT). Although earlier detection and the development of disease modifying treatment continues to be a primary focus of research and several potential compounds are under clinical trial, more prevention studies are needed. The […]

Continue reading


Cross Validation of the Montreal Cognitive Assessment in Community Dwelling Older Adults Residing in the Southeastern US

By Cheryl A. Luis, Andrew Keegan, and Michael Mullan Int J Geriatr Psychiatry. 2009 Feb;24(2):197-201. Suitable methods of earlier detection of memory changes, before the full onset of a dementia are needed.  Methods such as imaging for abnormal protein accumulation in the brain and lumbar puncture to measure abnormal proteins in cerebral spinal fluid are […]

Continue reading


Effect of NSAIDS on cognitive ability of Alzheimer’s Patients

Medications that reduce inflammation known as non-steroidal anti-inflammatory drugs (NSAIDS) do not improve thinking abilities in normal seniors. These findings from the Alzheimer’s Disease Anti-Inflammatory Prevention Trial (ADAPT) were published this month in Archives of Neurology. The Roskamp Institute Memory Clinic in Tampa was one of a handful of centers across the United States that […]

Continue reading